📰 Exp Med News
Page 2 - Exp Med News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exp Med. Real-time updates on events, politics, business and more.
February 24, 2022
This review summarizes progress in the development of peptide-based nanovaccines against HPV infection.
October 5, 2021
A remarkable number of life-threatening diseases manifest more seriously in males than in females. One current example is the COVID-19 illness caused
September 30, 2021
(BPT) - Sponsored by Jazz Pharmaceuticals
July 5, 2021
163 are also involved in resistance to cisplatin, temozolomide and 5-fluorouracil via altering glycolysis in gastric cancer, glioblastoma and CRC, respectively. Interestingly, Fu et al reported that lncRNA plasmacytoma variant translocation 1 (PVT1) maintains Myc expression in Sjögren’s syndrome. This expression regulates proliferation and immune effects of CD4 + T cells by controlling glycolytic metabolism. 164 Investigating the role of the PVT1-T cell glycolysis axis in tumor models may pr...
March 2, 2021
When it comes to immune health, it is essential for brand owners to determine what type of immune support they’re trying to provide through a formulation. Examples include: a. A person thinks they may be coming down with a cold or flu—they need something to stimulate immune response. b. A person has a chronic immune weakness such as allergies, colds, flu, etc. —they need something for long-term support of immune functionality. c. A person has an autoimmune or overactive immune response—...
January 27, 2021
By terrasig on March 16, 2010. This post is the third in a series on the origin and history of HeLa S3 cells. The first post details how I came about to ask this question when launching my independent research laboratory. The second post details the life and careers of the legendary physician-scientist pioneer, Dr. Florence Rena Sabin. Today, we take up a discussion where we will finally learn the origin of HeLa S3 cells, complete with original literature citations. A recap W...
January 19, 2021
SteveAllenPhoto / iStock Note: The views expressed in this commentary reflect the opinions of the authors and do not necessarily represent the policies or official positions of their organizations. Since the COVID-19 pandemic began roughly a year ago, public health officials have recorded more than 2 million deaths and almost 100 million infections from the SARS-CoV-2 virus, with the actual number likely substantially higher. Healthcare systems have been overwhelmed with caring for those suffer...
January 13, 2021
Share this article Share this article GERMANTOWN, Md., Jan. 13, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today presented clinical and preclinical updates at the 39th Annual J.P. Morgan Healthcare Conference. Helen Sabzevari, PhD, President and CEO of Precigen, presented a summary of 2020 clinical achievements and set forth Precigens clinical goals fo...
December 16, 2020
Posted December 16th, 2020 for Novartis Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening blood disorder, resulting in debilitating symptoms that can impact patients’ quality of life 1–3 C3 glomerulopathy (C3G) is a rare renal disease, affecting young patients with a poor prognosis and significant unmet need 4-5 With potential to be the first oral treatment for a range of complement-driven diseases, complement factor B inhibitor iptacopan targets the underlying...
December 15, 2020
Science Communication Opinion Share Post In this opinion piece, Andrei Surguchov, Professor of Neurology at University of Kansas Medical Center and Chief Editor of Biochemistry Research International, reflects on the impact the COVID-19 has had on the epidemic of neurodegenerative diseases and dementia. Lack of an active treatment strategy and vaccine makes SARS-CoV-2 infection an immense threat to humankind. The COVID-19 pandemic arrived when the world was already facing other rising health pr...